Literature DB >> 1309316

Role of nitric oxide in reactive hyperemia of the guinea pig heart.

M M Kostic1, J Schrader.   

Abstract

To evaluate the role of nitric oxide (NO) in the flow response after brief coronary arterial occlusion, NO formation by the isolated guinea pig heart was assessed by a specific difference spectrophotometric assay. Release of NO under basal conditions was 121.8 +/- 10.5 pmol x min-1 and increased to 211.1 +/- 16.8 pmol x min-1 after 60 seconds of coronary occlusion. Simultaneously, release of cGMP and adenosine increased by 87% and 652%, respectively. The kinetics of NO release paralleled the reactive hyperemic flow response. Inhibition of NO synthesis with nitro-L-arginine methyl ester (L-NAME, 30 microM) significantly reduced basal flow and attenuated reactive hyperemia, flow repayment, and repayment ratio. L-NAME decreased release of cGMP but significantly increased adenosine release under basal conditions and during reactive hyperemia. Oxyhemoglobin (5 microM) potentiated the effects of L-NAME. The stereoisomer nitro-D-arginine methyl ester was ineffective. Our results suggest 1) NO is an important regulator of coronary flow during reactive hyperemia as well as under basal flow conditions and 2) the significance of the increased adenosine release when NO synthesis is inhibited remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309316     DOI: 10.1161/01.res.70.1.208

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

1.  Effects of repeated brief episodes of ischemia and reperfusion in isolated perfused rat hearts.

Authors:  T Yasumura; N Aoki; A Yanagisawa; A Maki; C Shirato; K Ishikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Mechanical compression elicits NO-dependent increases in coronary flow.

Authors:  Dong Sun; An Huang; Gabor Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-12       Impact factor: 4.733

3.  Reperfusion Injury: Basic Concepts and Protection Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 4.  Coronary microcirculation: autoregulation and metabolic control.

Authors:  D V DeFily; W M Chilian
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

5.  Mediators of coronary reactive hyperaemia in isolated mouse heart.

Authors:  Amanda J Zatta; John P Headrick
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

6.  Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery.

Authors:  Alex L Huang; Annemarie E Silver; Elena Shvenke; David W Schopfer; Eiman Jahangir; Megan A Titas; Alex Shpilman; James O Menzoian; Michael T Watkins; Joseph D Raffetto; Gary Gibbons; Jonathan Woodson; Palma M Shaw; Mandeep Dhadly; Robert T Eberhardt; John F Keaney; Noyan Gokce; Joseph A Vita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-23       Impact factor: 8.311

7.  Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.

Authors:  M D Randall; H Ujiie; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Endothelial control of coronary flow in perfused guinea pig heart.

Authors:  R J Gryglewski; S Chlopicki; P Niezabitowski
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

9.  Glucagon effects on ischemic vasodilatation in the isolated rat heart.

Authors:  Mirko Rosic; Suzana Pantovic; Gvozden Rosic; Aleksandra Tomic-Lucic; Tatjana Labudovic; Vladimir Zivkovic; Vladimir Jakovljevic
Journal:  J Biomed Biotechnol       Date:  2010-03-18

10.  Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.

Authors:  A I McCulloch; M D Randall
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.